In the News: Partek Press Releases

St. Louis, Missouri – March 19, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Weill Medical College of Cornell University.

Weill Medical College of Cornell University has purchased Partek GS software to analyze genomic data. Scientists at the College are currently doing groundbreaking work in HIV research, vision research, cancer biology, and pharmacology. Weill Medical College was founded in 1898.

Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – March 17, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to University of Pennsylvania.

Partek GS will be used to analyze data from studies in the genetics of pediatric cancer. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – March 14, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Stanford University.

Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – March 12, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to CRP-Santé (Public Research Center for Health).

CRP-Santé does research in many different areas including cancer, cardiology, virology, allergies, immunobiology, mental health, hereditary diseases, environmental health, toxicology, and neuro-oncology. Researchers at the facility will use Partek GS to analyze cancer genomics data. CRP-Santé is located in Luxembourg.

Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – March 10, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to INMEGEN (National Institute of Genomic Medicine).

INMEGEN has purchased Partek GS to analyze both Affymetrix and Illumina data. INMEGEN, located in Mexico City, conducts research in the areas of lupus, cancer, obesity, and asthma.

Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – March 10, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Hospital Central de Asturias (HUCA).

Researchers at HUCA will use Partek GS to analyze gene expression data. HUCA ia located in Spain. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design.

St. Louis, Missouri – February 29, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Hamner Institutes for Health Sciences.

Hamner Institutes has purchased Partek GS to analyze gene expression data. Hamner Institutes, located in North Carolina, does research to develop new medications.

Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – February 28, 2008 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Carilion Clinic.

The Research Department at Carilion Clinic will use Partek GS to analyze data from research done on site. Partek GS can import and analyze raw and processed data from all major array platforms. Partek GS can analyze expression, digital gene expression, ChIP-seq/ChIP-chip, exon/alternative splicing, SNP genotyping, and next generation sequencing data. In addition, data can be seamlessly imported from a variety of file formats.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.